RinuaGene

Business Services · China · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Unit 201 Building 24 Phase Ii Biobay Ind...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About RinuaGene

RinuaGene Biotechnology, founded in 2021, focuses on the research and development of innovative mRNA therapies and vaccines to tackle significant health challenges globally. The company boasts a robust pipeline with potential first-in-class products in immunotherapy, in vivo protein replacement therapy, and prophylactic vaccines. RinuaGene has developed a comprehensive RNA R&D and CMC technological platform that enables efficient product development and manufacturing. Committed to improving human health, RinuaGene aims to deliver transformative solutions through its cutting-edge scientific expertise and technological advancements.Explore more
Popular SearchesRinuaGeneSIC Code 87,873NAICS Code 54,541Show more

RinuaGene Org Chart

PhoneEmail
JZ
China flag for contact location.

Strategic Operations Head

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is RinuaGene your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Top Business Services Companies

Frequently Asked Questions Regarding RinuaGene

What is RinuaGene's official website?
RinuaGene's official website is www.rinuagene.com
What is RinuaGene's Revenue?
RinuaGene's revenue is <$5 Million
What is RinuaGene's SIC code?
RinuaGene's SIC: 87,873
What is RinuaGene's NAICS code?
RinuaGene's NAICS: 54,541
How many employees does RinuaGene have?
RinuaGene has 11-50 employees
What industry does RinuaGene belong to?
RinuaGene is in the industry of: Business Services, Research & Development
What does RinuaGene do?

RinuaGene Biotechnology, founded in 2021, focuses on the research and development of innovative mRNA therapies and vaccines to tackle significant health challenges globally. The company boasts a robust pipeline with potential first-in-class products in immunotherapy, in vivo protein replacement therapy, and prophylactic vaccines. RinuaGene has deve... loped a comprehensive RNA R&D and CMC technological platform that enables efficient product development and manufacturing. Committed to improving human health, RinuaGene aims to deliver transformative solutions through its cutting-edge scientific expertise and technological advancements.Read More

Is RinuaGene a public company?
RinuaGene is private company therefore does not currently have an official ticker symbol
See more information about RinuaGene

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.